These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21087204)

  • 21. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
    Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
    Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.
    Gai H; Leung EL; Costantino PD; Aguila JR; Nguyen DM; Fink LM; Ward DC; Ma Y
    Cell Biol Int; 2009 Nov; 33(11):1184-93. PubMed ID: 19729070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.
    Mehta A; Verma V; Nandihalli M; Ramachandra CJ; Sequiera GL; Sudibyo Y; Chung Y; Sun W; Shim W
    PLoS One; 2014; 9(7):e103485. PubMed ID: 25068310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
    Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
    Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
    Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells.
    Bin Z; Sheng LG; Gang ZC; Hong J; Jun C; Bo Y; Hui S
    Cell Biol Int; 2006 Oct; 30(10):769-76. PubMed ID: 16831561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of endoderm formation efficiency between mouse ES cells and iPS cells.
    Iwamuro M; Komaki T; Kubota Y; Seita M; Kawamoto H; Yuasa T; Shahid JM; Hassan RA; Hassan WA; Nakaji S; Nishikawa Y; Kondo E; Yamamoto K; Kobayashi N
    Cell Transplant; 2010; 19(6):831-9. PubMed ID: 20955658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enrichment of cardiomyocytes derived from mouse embryonic stem cells.
    E LL; Zhao YS; Guo XM; Wang CY; Jiang H; Li J; Duan CM; Song Y
    J Heart Lung Transplant; 2006 Jun; 25(6):664-74. PubMed ID: 16730572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial development of the in vitro hepatic organogenesis model with simultaneous cardiac mesoderm differentiation from murine induced pluripotent stem cells.
    Tamai M; Yamashita A; Tagawa Y
    J Biosci Bioeng; 2011 Nov; 112(5):495-500. PubMed ID: 21816670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cell lines derived from adult human ventricular cardiomyocytes.
    Davidson MM; Nesti C; Palenzuela L; Walker WF; Hernandez E; Protas L; Hirano M; Isaac ND
    J Mol Cell Cardiol; 2005 Jul; 39(1):133-47. PubMed ID: 15913645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells.
    Hatami L; Valojerdi MR; Mowla SJ
    Int J Cardiol; 2007 Apr; 117(1):80-9. PubMed ID: 17034884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Working' cardiomyocytes exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells.
    Okamoto K; Miyoshi S; Toyoda M; Hida N; Ikegami Y; Makino H; Nishiyama N; Tsuji H; Cui CH; Segawa K; Uyama T; Kami D; Miyado K; Asada H; Matsumoto K; Saito H; Yoshimura Y; Ogawa S; Aeba R; Yozu R; Umezawa A
    Exp Cell Res; 2007 Jul; 313(12):2550-62. PubMed ID: 17544394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes.
    Lev S; Kehat I; Gepstein L
    Ann N Y Acad Sci; 2005 Jun; 1047():50-65. PubMed ID: 16093484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling of functional murine embryonic stem cell-derived cardiomyocytes and comparison with adult heart: profiling of murine ESC-derived cardiomyocytes.
    Shinozawa T; Tsuji A; Imahashi K; Nakashima K; Sawada H; Toyoshiba H; Yamamoto S; Takami K; Imai R
    J Biomol Screen; 2009 Mar; 14(3):239-45. PubMed ID: 19211779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of electrical stimulation on the differentiation of induced pluripotent stem cells into cardiomyocytes induced by vitamin C in vitro].
    Dai Y; Qin J; Zhang X; Zhang X; Chen C; Liao K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):364-7. PubMed ID: 23643166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells.
    Guan K; Wagner S; Unsöld B; Maier LS; Kaiser D; Hemmerlein B; Nayernia K; Engel W; Hasenfuss G
    Circ Res; 2007 Jun; 100(11):1615-25. PubMed ID: 17478732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control.
    Schroeder M; Niebruegge S; Werner A; Willbold E; Burg M; Ruediger M; Field LJ; Lehmann J; Zweigerdt R
    Biotechnol Bioeng; 2005 Dec; 92(7):920-33. PubMed ID: 16189818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies.
    Zweigerdt R; Burg M; Willbold E; Abts H; Ruediger M
    Cytotherapy; 2003; 5(5):399-413. PubMed ID: 14578102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.